Beranda › Penyakit Hati Steatotik › Illinois
Uji klinis Penyakit Hati Steatotik di Illinois
6 studi untuk Penyakit Hati Steatotik mencari peserta di lokasi di Illinois.
Kota di Illinois
Teks studi resmi (Bahasa Inggris)
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- University of Chicago Medical Center, Chicago
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Chicago
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06528314A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chicago
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Chicago
- 89bio Clinical Study Site, Glenview
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06419374Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- RUSH University Medical Center, Chicago
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT04054310Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
- Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Menerima pesertaFase 2
Usia 16 hingga 20 · Semua jenis kelamin · Diperbarui 21 Jan 2026 · NCT06355310Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.